Senior Scientist - Biopharmaceutical Product Development
Your Role
CSL are hiring a Senior Scientist within Biopharmaceutical Product Development (BPD) for a 12-month fixed term contract.
The Senior Scientist, in Immunoanalytics has accountability for the development and characterisation of mAbs for Seqirus’ SARS-CoV2 and influenza vaccine platforms.
You will provide a high level of scientific and technical expertise for the Surveillance and Vaccine Development group to support innovation and delivery of BPD/SVVD objectives, engagement with stakeholders at a local and international level, and to support departmental compliance.
Your Responsibilities
Reporting to the Associate Director, Immunoanalytics you will be responsible for:
- Monoclonal antibody (mAb) generation via established hybridoma process.
- Ensuring delivery of mAbs to support SARS-CoV2 and Influenza vaccine programs (development and life cycle management) and other CSL products as required.
- Animal ethics compliance.
- Supporting the characterisation of mAbs, expression of recombinant proteins and optimisation of immunoanalytics for Seqirus’ SARS-CoV2 and influenza vaccine platforms.
- Develop/implement and run analytics to support SARS-CoV2 surveillance within BPD.
- Provision of scientific and technical guidance for Surveillance and Vaccine Development group activities.
- Staff development to increase scientific and technical capability of Surveillance and Vaccine Development group and training less experienced scientists as required.
Your Experience
- Degree and/or experience in relevant discipline, PhD preferred.
- 5+ years’ experience in relevant field/industry.
- Practical expertise in the areas of virology, immunology, molecular biology, cell culture, analytical assay development or process development.
- Extensive experience in immunoassays and analytical development.
- Extensive experience with small animal models.
- Practical experience & expertise raising mAbs via hybridoma method.
- Experience with animal ethics applications and compliance.
- Ability to drive and deliver ongoing documentation and/or process improvements.
- Understanding of the timing requirements for the delivery of seasonal and pandemic influenza, and SARS-CoV2 vaccines
To apply, submit your CV no later than Monday 16th January 2024.
Our Benefits
CSL Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join CSL Seqirus.
About CSL Seqirus
CSL Seqirus is part of CSL Limited (ASX: CSL). As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. In Australia, CSL Seqirus is also a leading provider of speciality pharmaceuticals and other essential vaccines. Learn more about CSL Seqirus.
We want CSL Seqirus to reflect the world around us
As a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL Seqirus.
Do work that matters at CSL Seqirus!
Watch our ‘On the Front Line’ video to learn more about CSL Seqirus
Your Role
CSL are hiring a Senior Scientist within Biopharmaceutical Product Development (BPD) for a 12-month fixed term contract.
The Senior Scientist, in Immunoanalytics has accountability for the development and characterisation of mAbs for Seqirus’ SARS-CoV2 and influenza vaccine platforms.
You will provide a high level of scientific and technical expertise for the Surveillance and Vaccine Development group to support innovation and delivery of BPD/SVVD objectives, engagement with stakeholders at a local and international level, and to support departmental compliance.
Your Responsibilities
Reporting to the Associate Director, Immunoanalytics you will be responsible for:
- Monoclonal antibody (mAb) generation via established hybridoma process.
- Ensuring delivery of mAbs to support SARS-CoV2 and Influenza vaccine programs (development and life cycle management) and other CSL products as required.
- Animal ethics compliance.
- Supporting the characterisation of mAbs, expression of recombinant proteins and optimisation of immunoanalytics for Seqirus’ SARS-CoV2 and influenza vaccine platforms.
- Develop/implement and run analytics to support SARS-CoV2 surveillance within BPD.
- Provision of scientific and technical guidance for Surveillance and Vaccine Development group activities.
- Staff development to increase scientific and technical capability of Surveillance and Vaccine Development group and training less experienced scientists as required.
Your Experience
- Degree and/or experience in relevant discipline, PhD preferred.
- 5+ years’ experience in relevant field/industry.
- Practical expertise in the areas of virology, immunology, molecular biology, cell culture, analytical assay development or process development.
- Extensive experience in immunoassays and analytical development.
- Extensive experience with small animal models.
- Practical experience & expertise raising mAbs via hybridoma method.
- Experience with animal ethics applications and compliance.
- Ability to drive and deliver ongoing documentation and/or process improvements.
- Understanding of the timing requirements for the delivery of seasonal and pandemic influenza, and SARS-CoV2 vaccines
To apply, submit your CV no later than Monday 16th January 2024.
Our Benefits
CSL Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join CSL Seqirus.
About CSL Seqirus
CSL Seqirus is part of CSL Limited (ASX: CSL). As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. In Australia, CSL Seqirus is also a leading provider of speciality pharmaceuticals and other essential vaccines. Learn more about CSL Seqirus.
We want CSL Seqirus to reflect the world around us
As a global organisation with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL Seqirus.
Do work that matters at CSL Seqirus!
Watch our ‘On the Front Line’ video to learn more about CSL Seqirus
< Back to list